Tenderfy

78129 RH KLM IMM Production instrument for cell therapy.

Hankija
Oslo Universitetssykehus HF (hovedenhet)
Avaldatud
2026-09-21
Tähtaeg
2026-10-26T11:00:00+00:00
Allikad
TED
Väärtus
Pole esitatud

Kirjeldus

Kirjeldus on allika keeles.

The contracting authority invites tenderers to a competition for the procurement of a production instrument for cell therapy at Rikshospitalet, the Department for Immunology and Transfusion Medicine, Section for ex vivo cell laboratory. The instrument system shall be used for GMP compatible final processing of cell therapy products (ATMP), including CAR-T cells. The system shall support a standardised, automated and functionally closed work flow for final processing of cell products. This includes i.a. formulation, addition of formulation buffer and cryoprotectant, homogenisation, aliquotation, filling and sealing of final containers. The scope of the agreement is for the procurement of one instrument, with an option for a further one instrument with software as well as the accompanying consumables. In addition options shall be offered on service agreements/servicing.

CPV: 33000000, 38000000

Liikmesus

Teadete eelvaated on tasuta. Ametlike teadete ja dokumentide lingid, ehitusload ning isiklik MCP juurdepääs nõuavad aktiivset tasulist liikmesust.

Loe